These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 31319469)

  • 1. Genetic Deletion or Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Cardiac Ischemia/Reperfusion Injury by Attenuating NLRP3 Inflammasome Activation.
    Darwesh AM; Keshavarz-Bahaghighat H; Jamieson KL; Seubert JM
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31319469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotective effects of CYP-derived epoxy metabolites of docosahexaenoic acid involve limiting NLRP3 inflammasome activation
    Darwesh AM; Jamieson KL; Wang C; Samokhvalov V; Seubert JM
    Can J Physiol Pharmacol; 2019 Jun; 97(6):544-556. PubMed ID: 30326194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function.
    Sosnowski DK; Jamieson KL; Gruzdev A; Li Y; Valencia R; Yousef A; Kassiri Z; Zeldin DC; Seubert JM
    Am J Physiol Heart Circ Physiol; 2022 Oct; 323(4):H670-H687. PubMed ID: 35985007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Synthetic Epoxydocosapentaenoic Acid Analogue Ameliorates Cardiac Ischemia/Reperfusion Injury: The Involvement of the Sirtuin 3-NLRP3 Pathway.
    Darwesh AM; Bassiouni W; Adebesin AM; Mohammad AS; Falck JR; Seubert JM
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
    Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Inhibition of NLRP3 Inflammasome Attenuates Myocardial Ischemia/Reperfusion Injury by Activation of RISK and Mitochondrial Pathways.
    Mastrocola R; Penna C; Tullio F; Femminò S; Nigro D; Chiazza F; Serpe L; Collotta D; Alloatti G; Cocco M; Bertinaria M; Pagliaro P; Aragno M; Collino M
    Oxid Med Cell Longev; 2016; 2016():5271251. PubMed ID: 28053692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic deletion of soluble epoxide hydrolase provides cardioprotective responses following myocardial infarction in aged mice.
    Jamieson KL; Samokhvalov V; Akhnokh MK; Lee K; Cho WJ; Takawale A; Wang X; Kassiri Z; Seubert JM
    Prostaglandins Other Lipid Mediat; 2017 Sep; 132():47-58. PubMed ID: 28104457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linoleic Acid Metabolite DiHOME Decreases Post-ischemic Cardiac Recovery in Murine Hearts.
    Bannehr M; Löhr L; Gelep J; Haverkamp W; Schunck WH; Gollasch M; Wutzler A
    Cardiovasc Toxicol; 2019 Aug; 19(4):365-371. PubMed ID: 30725262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.
    Seubert JM; Sinal CJ; Graves J; DeGraff LM; Bradbury JA; Lee CR; Goralski K; Carey MA; Luria A; Newman JW; Hammock BD; Falck JR; Roberts H; Rockman HA; Murphy E; Zeldin DC
    Circ Res; 2006 Aug; 99(4):442-50. PubMed ID: 16857962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel soluble epoxide hydrolase inhibitor protects mitochondrial function following stress.
    Batchu SN; Lee SB; Samokhvalov V; Chaudhary KR; El-Sikhry H; Weldon SM; Seubert JM
    Can J Physiol Pharmacol; 2012 Jun; 90(6):811-23. PubMed ID: 22624559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP3 Inflammasome in Cardioprotective Signaling.
    Zuurbier CJ
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):271-275. PubMed ID: 31356546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
    Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X
    Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F
    J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase activation by S-nitrosation contributes to cardiac ischemia-reperfusion injury.
    Ding Y; Li Y; Zhang X; He J; Lu D; Fang X; Wang Y; Wang J; Zhang Y; Qiao X; Gan LM; Chen C; Zhu Y
    J Mol Cell Cardiol; 2017 Sep; 110():70-79. PubMed ID: 28736260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
    Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
    Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-2 proteolyzes mitofusin-2 and impairs mitochondrial function during myocardial ischemia-reperfusion injury.
    Bassiouni W; Valencia R; Mahmud Z; Seubert JM; Schulz R
    Basic Res Cardiol; 2023 Jul; 118(1):29. PubMed ID: 37495895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Epoxide Hydrolase in Aged Female Mice and Human Explanted Hearts Following Ischemic Injury.
    Jamieson KL; Darwesh AM; Sosnowski DK; Zhang H; Shah S; Zhabyeyev P; Yang J; Hammock BD; Edin ML; Zeldin DC; Oudit GY; Kassiri Z; Seubert JM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epoxyeicosatrienoic acids inhibit the activation of NLRP3 inflammasome in murine macrophages.
    Luo XQ; Duan JX; Yang HH; Zhang CY; Sun CC; Guan XX; Xiong JB; Zu C; Tao JH; Zhou Y; Guan CX
    J Cell Physiol; 2020 Dec; 235(12):9910-9921. PubMed ID: 32452554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of autophagy inhibits nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome activation and attenuates myocardial ischemia-reperfusion injury in diabetic rats.
    Zhang D; He Y; Ye X; Cai Y; Xu J; Zhang L; Li M; Liu H; Wang S; Xia Z
    J Diabetes Investig; 2020 Sep; 11(5):1126-1136. PubMed ID: 32064785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades.
    Penna C; Aragno M; Cento AS; Femminò S; Russo I; Bello FD; Chiazza F; Collotta D; Alves GF; Bertinaria M; Zicola E; Mercurio V; Medana C; Collino M; Pagliaro P
    Oxid Med Cell Longev; 2020; 2020():9219825. PubMed ID: 32832010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.